Stockreport

EXCLUSIVE: Telomir Pharmaceuticals Reports Potential Of Telomir-1 For Wilson's Disease [Yahoo! Finance]

Telomir Pharmaceuticals, Inc.  (TELO) 
PDF On Monday, Telomir Pharmaceuticals, Inc. (NASDAQ: TELO ) announced preclinical findings highlighting the copper-binding potential of its lead compound, Telomir-1, as a [Read more]